Therapeutic adherence in hyperlipidemia: When one size doesn't fit all

被引：7

作者：

Dal Pino, Beatrice ^{[1
]}

Sbrana, Francesco ^{[1
]}

机构：

[1] Fdn Toscana Gabriele Monasterio, Lipoapheresis Unit, Reference Ctr Diag & Treatment Inherited Dyslipid, Via Moruzzi 1, I-56124 Pisa, Italy

来源：

EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 112卷

关键词：

Cardiovascular disease; Hyperlipidemia; Lipid lowering therapy; Statins; Therapeutic adherence; PATIENT ADHERENCE;

D O I：

10.1016/j.ejim.2023.03.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：143 / 145

页数：3

共 12 条

[1]

Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P1

[2]

[Anonymous], 1993, GAZZETTA UFFICIALE

[3] Persistence of use of lipid-lowering medications - A cross-national study [J].

Avorn, J ;

Monette, J ;

Lacour, A ;

Bohn, RL ;

Monane, M ;

Mogun, H ;

LeLorier, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1458-1462

[4] A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia [J].

Blom, Dirk J. ;

Hala, Tomas ;

Bolognese, Michael ;

Lillestol, Michael J. ;

Toth, Phillip D. ;

Burgess, Lesley ;

Ceska, Richard ;

Roth, Eli ;

Koren, Michael J. ;

Ballantyne, Christie M. ;

Monsalvo, Maria Laura ;

Tsirtsonis, Kate ;

Kim, Jae B. ;

Scott, Rob ;

Wasserman, Scott M. ;

Stein, Evan A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19) :1809-1819

[5] Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience [J].

Gragnano, Felice ;

Natale, Francesco ;

Concilio, Claudia ;

Fimiani, Fabio ;

Cesaro, Arturo ;

Sperlongano, Simona ;

Crisci, Mario ;

Limongelli, Giuseppe ;

Calabro, Raffaele ;

Russo, Mariagiovanna ;

Golia, Enrica ;

Calabro, Paolo .

JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (02) :75-77

[6] FROM THE ANALYST'S COUCH The dyslipidaemia market [J].

Hudson, Victoria .

NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (11) :807-807

[7] Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study [J].

Kereiakes, Dean J. ;

Robinson, Jennifer G. ;

Cannon, Christopher P. ;

Lorenzato, Christelle ;

Pordy, Robert ;

Chaudhari, Umesh ;

Colhoun, Helen M. .

AMERICAN HEART JOURNAL, 2015, 169 (06) :906-+

[8]

Lugoboni Fabio, 2004, Ann Ital Med Int, V19, P155

[9] Interventions to enhance patient adherence to medication prescriptions - Scientific review [J].

McDonald, HP ;

Garg, AX ;

Haynes, RB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (22) :2868-2879

[10] Drug therapy - Adherence to medication [J].

Osterberg, L ;

Blaschke, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (05) :487-497

← 1 2 →